Ma'anar In Vitro Diagnostic
Binciken In Vitro (IVD) yana nufin hanyar bincike da ke samun bayanan ganewar asali ta hanyar tattarawa da kuma bincika samfuran halittu, kamar jini, yau, ko nama, don gano cutar, magance ta, ko hana ta. Binciken In Vitro muhimmin tushe ne na ganewar asali na asibiti, wanda zai iya samar da mahimman bayanai na tunani don shirye-shiryen maganin likitoci. IVD wani bangare ne mai mahimmanci na tsarin likitanci don tabbatar da lafiyar ɗan adam.

Rarraba Kasuwar IVD
Dangane da rarrabuwar ka'idodin gwaji, ana iya raba ɓangaren kasuwar IVD zuwa Microbiology, Clinical Chemistry, Hematology, Coagulation, Immunoassay, Molecular Diagnostics, POCT, da sauransu. Dangane da rarrabuwar samfurin gwajin, ana iya raba kasuwar IVD zuwa reagents, kayan aiki, da ayyuka.

Juyin Halittar IVD
Mataki na 1:
Ƙirƙirar na'urar hangen nesa ta haifar da wasu hanyoyin gwaji na gargajiya.

Mataki na 2:
Ci gaban magungunan zamani da kuma gano halayen da aka samar da enzyme da kuma halayen antigen-antibody sun kafa harsashin gano kwayoyin halitta da kuma maganin rigakafi, don haka binciken in vitro yana ƙaruwa kuma yana faɗaɗa a hankali a wannan lokacin.

Mataki na 3:
Amfani da tsarin DNA mai siffar helix guda biyu, fasahar rigakafi ta monoclonal, da fasahar alamomin macromolecular sun haɓaka ci gaban masana'antar ganewar ƙwayoyin cuta a cikin vitro.

Kasuwar IVD ta Duniya
Sama da kashi 70% na kasuwar IVD ta duniya tana hannun Turai, Arewacin Amurka da Japan. Manyan 'yan wasa na ƙasashen duniya guda huɗu sune Roche (Switzerland), Abbott (Amurka), Thermo (Amurka) da Siemens (Jamus). Waɗannan kamfanoni huɗu suna da jimillar kaso na kasuwar duniya na kusan kashi 51% a shekarar 2017.